Pediatrix Medical (MD) Long-Term Deferred Tax (2018 - 2026)
Pediatrix Medical (MD) has disclosed Long-Term Deferred Tax for 8 consecutive years, with $216.9 million as the latest value for Q4 2025.
- Quarterly Long-Term Deferred Tax rose 108.89% to $216.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $216.9 million through Dec 2025, up 108.89% year-over-year, with the annual reading at $216.9 million for FY2025, 108.89% up from the prior year.
- Long-Term Deferred Tax for Q4 2025 was $216.9 million at Pediatrix Medical, up from $79.8 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $216.9 million in Q4 2025, with the low at $46.9 million in Q4 2021.
- Average Long-Term Deferred Tax over 5 years is $96.9 million, with a median of $98.6 million recorded in 2022.
- Peak annual rise in Long-Term Deferred Tax hit 545.24% in 2021, while the deepest fall reached 46.63% in 2021.
- Over 5 years, Long-Term Deferred Tax stood at $46.9 million in 2021, then surged by 54.04% to $72.3 million in 2022, then skyrocketed by 42.26% to $102.9 million in 2023, then grew by 0.98% to $103.9 million in 2024, then surged by 108.89% to $216.9 million in 2025.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $216.9 million, $79.8 million, and $88.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.